China's Leading Inhalation Drug Delivery Platform
Hangzhou Chance Pharmaceuticals is a fast growing Hi-tech company who focuses on research, development and commercialization of inhalation products specialized on DPIs for local and systematic indications. Managed by a team with global vision and full spectrum of drug development including research, clinical development, regulatory as well as commercialization. Chance is establishing a sustainable and global market-value oriented product pipeline covering respiratory and systematic indications by Chance’s proprietary pulmonary drug delivery platform technology including novel particle engineering, unique inhaler design as well as inhaler manufacture partnered with international top-tier manufacturers. Chance’s mission is to provide better, safer, cheaper, easy-to-use products to improve patients’ quality of daily life and to create the optimal overall reward to our valuable investors.